FDA Clears COVID Booster Shot For Healthy Kids Ages 5 To 11

Pfizer has requested approval for a booster shot, citing data that shows a significant increase in omicron-fighting antibodies in children aged 5 to 11. The company reported that 4,500 children participated in their vaccine trial with no safety concerns. The CDC's advisory committee is expected to discuss COVID boosters in an upcoming meeting.

What new insight or understanding did you gain from this video?